Welcome to the Office of Research and Development
The Office of Research and Development houses the University's research administration, corporate contract and technology commercialization efforts and leads global and economic development initiatives including the University of Maryland BioPark and Global Health Initiatives. Our staff is available to assist you.
Please visit our web portal for more information: Research @ UM
James L. Hughes
News and Announcements
Entrepreneur of the Year 2014: James Gammie, MD, inventor and co-founder of Harpoon Medical, Inc.
Proposal Approvers: Proposal approval in Kuali Coeus. Please review this brief (less than 5 minutes) tutorial!
International Travel Security information: Passengers traveling on any airline to the U.S. from select airports in Europe, the Middle East, and Africa should expect additional security measures relative to carry-on items. All battery-operated electronic devices intended for carry-on must be operational, including tablets, phones, e-readers, and laptops. If the device cannot be powered on it will not travel on the flight and could be confiscated. Travelers should be mindful of this and limit use of electronics as needed to ensure that they have power when passing through all security checkpoints. Passengers are encouraged to allow an additional 30-45 minutes at the airport to account for these and other additional screening requirements. These measures have been extended to include some flights to and from the U.K. regardless of destination or origin, and some flights within the U.S.
Researcher Uses Microscopic Particles to Deliver Drugs into Teeth - Read the SOD News article (7/14/14)
Institute for Genome Sciences awarded $15.2 million grant by NIAID - Read the UMB News article (7/1/14)
University of Maryland Scientists Identify New Microbes Linked to Severe Diarrhea - Read the SOM News article (6/30/14)
NIH Awards $10.7 Million to University of Maryland School of Medicine’s 'Maryland Psychiatric Research Center' - Read the SOM News article (6/24/14)
Cyclotron Arrival: A Construction Milestone for the Maryland Proton Treatment Center at UM BioPark - Read the SOM News article (6/16/14)
ORD congratulates 14 certificate-earners from the Guide to the Administration of Sponsored Projects, a 12-session curriculum designed to introduce rising and new research administrators to a broad range of topics including budget development, award terms and conditions, monitoring expenses and receivables, personnel and payroll, invention disclosure, and records retention. Subject matter experts from central administration and departments lead the sessions. To date, 191 research administrators have completed the program since its inception eleven years ago. Many more have attended individual sessions for professional development.View larger photo.
Simeon Taylor, MD, PhD, to fill newly-created UMB position encouraging research, industry partnerships - Read the UMB press release (5/30/14)
New Experimental Vaccine Produces Immune Response against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - Read the SOM News article (4/30/14)
Entrepreneurial lecture hosted by School of Pharmacy with UM Ventures - Read the SOP News article (12/4/13)
International businessman, entrepreneur, and UM School of Pharmacy alumnus Dr. John M. Gregory was one of the very first entrepreneurial success stories on the UMB campus.
The Global Health Interprofessional Council hosted a roundtable conference on "Building Global Health Team Excellence" on October 25th. Forty two invited experts in interprofessional education (IPE) and global health education worked together in six small groups for a day determining what IPE concepts (e.g., communication, shared values, team work) should be part of a well-designed global health education program. View photos from the conference
Gliknik Enters Into Licensing Agreement With Pfizer For Drug Candidate Targeting Autoimmune Diseases - Gliknik press release (9/30/13)
NIH Renews Funding for UM Vaccine Research in Response to Emerging Public Health Issues - Read the UMB News article (9/27/13)
MedImmune and University of Maryland, Baltimore Announce Five-year, $6 Million Research Collaboration to Drive Science Innovation in Maryland
Collaboration to drive novel bioscience research - MedImmune Press Release (9/25/13)
UMB, MedImmune form partnership to advance biomedical science and innovation - Read the UMB News article (9/25/13)
UM's 2013 Entrepreneur of the Year, Dr. Magaly Rodriguez de Bittner - read more
UM's 2013 Researcher of the Year, Dr. W. Jonathan Lederer - read more
UMB's Partnership with Rexahn Pharmaceuticals - Exclusive license to Rexahn for development of cancer drug delivery platform co-developed by researchers at UMB's School of Pharmacy (7/17/13) - Press Release (PDF): Rexahn Pharmaceuticals In-Licenses Breakthrough Oncology Drug Delivery Platform: Maximizes efficacy and minimizes toxicity of currently marketed anti-cancer drugs RX-21101 identified as first development candidate from platform
Maryland Industrial Partnerships funds UMB Investigators - UMD Program Awards $3.8 Million to 17 University, Maryland Company Teams to Develop Technology Products - Wall Street Journal (7/16/13) - University of Maryland tech program awards $3.8M to researchers - Baltimore Business Journal (7/16/13)
University of Maryland Establishes Center for Health-Related Informatics and Bioimaging - Read the SOM News Article (6/10/13)
2013 USM Entrepreneur of the Year - Scott Strome - Watch the video!
USM Board of Regents Honors 3 Winners of Inaugural Entrepreneur of the Year Award: Winners' Entrepreneurial Success Reflected in Support of UM Ventures - Read the USM News Article (5/14/13)
Comparative Effectiveness Research interprofessional work group - resources, funding opportunities, and how to join